THREAD Launches Offering to Support Global DCT Adoption
THREAD has announced the launch of a new service offering, THREAD Adopt. This consultative service provides the tools, team, and knowledge to enable research sponsors to evaluate their study pipelines and configure a decentralized clinical trial (DCT) model for adoption at scale.
THREAD Adopt provides:
- repeatable processes, tools, and templates
- scalable education
- action plans to increase participant inclusivity
- clear steps aiming to increase workflow and cost efficiency at the next level of scale
- key performance indicators (KPIs)
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Tirzepatide Demonstrates Superior Weight Loss to Semaglutide in 72-Week Phase IIIb SURMOUNT-5 Trial
May 12th 2025In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist tirzepatide (Zepbound) delivered significantly greater and sustained weight loss than semaglutide (Wegovy) over 72 weeks in adults with obesity or overweight and comorbidities.
